HIV-1 Tat Interactive Protein 2, 30kDa (HTATIP2) Peptid
Kurzübersicht für HIV-1 Tat Interactive Protein 2, 30kDa (HTATIP2) Peptid (ABIN8102630)
Target
Quelle
Applikation
-
-
Verwendungszweck
- HTATIP2 Peptide
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-HTATIP2 antibody ( ARP32774_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- HIV-1 Tat Interactive Protein 2, 30kDa (HTATIP2)
-
Hintergrund
-
Background Information: CC3 (HTATIP2) is a member of the short-chain dehydrogenases/reductases (SDR) family. It is a novel serine/threonine kinase that phosphorylates the C-terminal domain (CTD) of the largest RNA polymerase II subunit and induces the expression of apoptosis related genes Bad and Siva, as well as metastasis suppressor NM23-H2. It also interacts with an estrogen receptor alpha-interacting coactivator CIA and regulates ERalpha-mediated c-myc transcription.
Alternative Symbols: CC3, TIP30, SDR44U1
-
Molekulargewicht
- 27kDa
-
Gen-ID
- 10553
-
NCBI Accession
- NP_006401
-
UniProt
- O15383
Target
-
